Ashwagandha and Shilajit for Testosterone and “Timing”: Trials vs Ads
Ashwagandha and purified shilajit have narrow testosterone and sperm evidence in selected groups. Neither has convincing trial evidence for delaying ejaculation.
Asked at 2am. Answered from sources.
Ashwagandha and shilajit are often sold as if they have passed one combined examination: testosterone up, sperm up, stamina up, “timing” up. The trials did not ask all of those questions. Some measured hormones, some measured semen, a few measured sexual questionnaires, and the key premature-ejaculation outcome—stopwatch or estimated ejaculation latency—is largely missing.
The claim table
| Advertising claim | Ashwagandha evidence | Shilajit evidence | Verdict |
|---|---|---|---|
| Raises testosterone | Some small trials over 2–4 months show increases in selected male groups. | One placebo-controlled purified-product trial in men aged 45–55 showed increases in total/free testosterone over 90 days. | Possible, narrow—not a treatment for diagnosed hypogonadism. |
| Improves sperm parameters | Evidence is strongest in men with low sperm counts; pregnancy/live-birth outcomes are not established. | Small purified-product studies in oligospermia report sperm improvements. | Promising but incomplete. |
| Improves erections and desire | Questionnaire results are mixed by population and extract; one crossover trial found hormone change without significant between-group sexual-well-being difference. | Not the primary strength of the cited trials. | Unsettled. |
| Delays ejaculation / improves “timing” | No robust trial evidence with IELT as the endpoint. | No robust trial evidence with IELT as the endpoint. | Unsupported. |
| Safe because natural | Rare liver injury, thyroid effects and medicine interactions are documented concerns. | Composition and heavy-metal contamination vary; raw material is not trial material. | False as a blanket claim. |
Ashwagandha: hormone signal, extract-specific
The US National Center for Complementary and Integrative Health summarises the evidence cautiously: limited data suggest taking ashwagandha for two to four months may increase testosterone and sperm quality. It also notes that many studies are small and use different preparations.
In a randomised, double-blind, placebo-controlled crossover study of overweight men aged 40–70 with mild fatigue, an extract delivering 21 mg of withanolide glycosides daily was associated with a 14.7% greater increase in salivary testosterone than placebo over eight weeks. The same study found no statistically significant between-group difference in sexual well-being. Of 57 enrolled participants, 43 completed all 16 weeks.
Earlier ashwagandha research in oligospermic men—men with low sperm concentration—has reported increases in sperm concentration, semen volume and motility. A supplement label that transfers those findings to every healthy 22-year-old worried about lasting longer has changed both the population and the outcome.
Shilajit: the strongest trial used a purified product
Pandit and colleagues randomised healthy volunteers aged 45–55 to purified shilajit 250 mg twice daily or placebo for 90 days. Total testosterone, free testosterone and DHEAS increased significantly compared with placebo, while LH and FSH were maintained. That is a real clinical-trial signal.
It is also a bounded one. The product was purified and standardised for the study. It does not validate dark resin scraped, blended or imported under the same name with unknown composition. Nor does a testosterone result in healthy middle-aged volunteers prove delayed ejaculation, better erections or fertility in a different group.
| What the trial protects | What a marketplace product may not share |
|---|---|
| Named/purified test material | Unknown source rock/resin, extraction and blending |
| Fixed dose and duration | Variable serving size and proprietary mixtures |
| Screened volunteers | People with thyroid, liver, kidney, prostate or fertility conditions |
| Prespecified hormone outcomes | Testimonials about stamina, timing and confidence |
| Quality testing for the study supply | No batch certificate, or a certificate that does not match the sold batch |
Safety is not a footnote
For ashwagandha, NCCIH says short-term use up to about three months may be safe for many adults, but long-term safety is not established. It lists drowsiness, stomach upset, diarrhoea and vomiting; rare cases of liver injury; avoidance during pregnancy and breastfeeding; and caution or non-use with thyroid/autoimmune disorders, impending surgery and hormone-sensitive prostate cancer. Interactions may involve diabetes and blood-pressure medicines, immunosuppressants, sedatives, anti-seizure medicines and thyroid hormone.
For shilajit, the central safety question is identity and contamination. Composition varies by source and processing, and analyses have raised concerns about heavy metals in some preparations. A certificate should identify the actual batch and test for contaminants; a generic “lab tested” badge is not enough.
The word “timing” is where the evidence disappears
Testosterone is not a stopwatch. Sperm concentration is not a stopwatch. A vitality questionnaire is not a stopwatch. To support a premature-ejaculation claim, a study would need men who meet a defined PE pattern, randomisation, a credible control, and an outcome such as stopwatch IELT, perceived control and distress. Neither supplement’s commonly cited testosterone trials supply that chain.
If fast ejaculation is the concern, start by separating occasional speed from lifelong or acquired premature ejaculation. Our stopwatch-duration guide explains the clinical thresholds.
Before buying, ask five questions
- What exact extract or purified material was used in the human trial?
- Does this label disclose that material and amount, or hide it in a blend?
- Was the outcome testosterone, semen, erections or ejaculation latency?
- Who should not take it, and which medicines interact?
- Is there a batch-specific contaminant certificate?
Bottom line
Ashwagandha and purified shilajit have limited human evidence for testosterone and some semen outcomes in selected groups. They do not have convincing evidence for delaying ejaculation. Treat “timing” claims as advertising until a trial measures timing.
Sources checked 21 October 2026:
- NCCIH: Ashwagandha—Usefulness and Safety
- Lopresti et al.: Ashwagandha in aging, overweight males—randomised crossover study
- Pandit et al.: Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers
- Role of Withania somnifera in the management of male infertility
- The Conversation: shilajit testosterone evidence and contamination concerns
This article does not recommend a supplement or dose. Do not use hormone claims to delay assessment of infertility, erectile change or premature ejaculation.
